ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2343

A Genome-Wide Association Study Suggests the HLA Class II Region As the Major Susceptibility Locus for IgA Vasculitis

Raquel López-Mejías1, Sara Remuzgo-Martínez1, Fernanda Genre1, Francisco David Carmona2, Santos Castañeda3, Belén Sevilla Pérez4, Norberto Ortego Centeno4, Javier Llorca5, Begoña Ubilla1, Veronica Mijares1, Trinitario Pina6, Jose A. Miranda-Filloy7, Antonio Navas Parejo8, Diego Argila9, Maximiliano Aragües10, Esteban Rubio-Romero11, Manuel Leon Luque12, Juan María Blanco Madrigal13, Eva Galindez-Agirregoikoa13, David Jayne14, Ricardo Blanco1, Javier Martin15 and Miguel Angel González-Gay16, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, 2Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Departamento de Genética e Instituto de Biotecnología, University of Granada, Granada, Spain, 3Hospital Universitario La Princesa. IIS-IP. Madrid. Spain, Madrid, Spain, 4Medicine Department, Hospital Universitario San Cecilio, Granada, Spain, 5Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, 6Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, 7Rheumatology Division, Hospital Lucus Augusti, Lugo, Spain, 8Nephrology Department, Hospital Universitario San Cecilio, Granada, Spain, 9Dermatology Department, Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain, 10Dermatology Department, Hospital Universitario La Princesa, IIS-Princesa, MAdrid, Spain, 11Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, 12Rheumatology Department,Hospital Universitario Virgen del Rocío, Sevilla, Spain, 13Rheumatology Division, Hospital Universitario de Basurto, Bilbao, Spain, 14Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 15Instituto de Parasitología y Biomedicina López-Neyra, Granada, Spain, 16Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL and School of Medicine, University of Cantabria, Santander, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: genetics and vasculitis, GWAS

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Pediatric Rheumatology – Pathogenesis and Genetics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Immunoglobulin-A (IgA) vasculitis, also known as Henoch-Schöenlein purpura (HSP), is the most common type of primary small-sized blood vessel leukocytoclastic vasculitis in children, although it may also develop in adults [1]. IgA vasculitis has a multifactorial etiology in which both environmental and genetic factors seem to contribute to the predisposition and clinical phenotype of the disease [1,2]. However, the genetic component of this type of vasculitis remains poorly understood, as only a few candidate gene studies have been performed to date [3,4]. Taking these considerations into account, and to increase the current knowledge on the genetic component of this vasculitis, we performed the first genome-wide association study (GWAS) on this condition using the largest series of IgAV patients of European ancestry ever assessed for a genetic study.

Methods: 308 IgA vasculitis patients and 1,018 healthy controls from Spain were genotyped by Illumina HumanCore BeadChips. Imputation of GWAS data was performed using the 1000 Genomes Project Phase III dataset as reference panel [5]. After quality control filters and GWAS imputation, 285 patients and 1,006 controls remained in the datasets and were included in further analysis. Additionally, the human leukocyte antigen (HLA) region was comprehensively studied by imputing classical alleles and polymorphic amino acid positions [6].

Results: A linkage disequilibrium block of polymorphisms located in the HLA class II region surpassed the genome-wide level of significance (odds ratio = 0.56, 95% confidence intervals = 0.46-0.68). Although no polymorphic amino acid positions were associated at the genome-wide level of significance, P-values of potential relevance were observed for the positions 13 and 11 of HLA-DRB1 (P = 6.67E-05, P = 1.88E-05, respectively). Outside the HLA, potential associations were detected, but none of them were close to the statistical significance.

Conclusion: Our study suggests that IgA vasculitis is an archetypal HLA class II disease.

[1] Gonzalez-Gay et al. Rheum Dis Clin North Am 2001, 27:729-49; [2] Wyatt et al. N Engl J Med 2013, 368:2402-14; [3] López-Mejías et al. Arthritis Res Ther 2015,17:102; [4] López-Mejías et al. Arthritis Rheumatol 2014;67:823-7; [5] Howie et al. PLoSGenet 2009;5: e1000529. [6] Carmona et al. Am J Hum Genet 2015;96:565-80.

This study is supported by European Union FEDER funds and “Fondo de Investigaciones Sanitarias” (grant PI12/00193) from ‘Instituto de Salud Carlos III’ (ISCIII, Health Ministry, Spain). RL-M is supported by the Miguel Servet I programme of the Spanish Ministry of Economy and Competitiveness through the grant CP16/00033. SR-M is supported by funds from the RETICS Program (RIER) (RD16/0012/0009). FG is recipient of a Sara Borrell postdoctoral fellowship from the “Instituto Carlos III de Salud” at the Spanish Ministry of Health (Spain) (CD15/00095). FDC is supported by the Ramón y Cajal programme of the Spanish Ministry of Economy and Competitiveness through the grant RYC-2014-16458.


Disclosure: R. López-Mejías, None; S. Remuzgo-Martínez, None; F. Genre, None; F. D. Carmona, None; S. Castañeda, None; B. Sevilla Pérez, None; N. Ortego Centeno, None; J. Llorca, None; B. Ubilla, None; V. Mijares, None; T. Pina, None; J. A. Miranda-Filloy, None; A. Navas Parejo, None; D. Argila, None; M. Aragües, None; E. Rubio-Romero, None; M. Leon Luque, None; J. M. Blanco Madrigal, None; E. Galindez-Agirregoikoa, None; D. Jayne, None; R. Blanco, None; J. Martin, None; M. A. González-Gay, None.

To cite this abstract in AMA style:

López-Mejías R, Remuzgo-Martínez S, Genre F, Carmona FD, Castañeda S, Sevilla Pérez B, Ortego Centeno N, Llorca J, Ubilla B, Mijares V, Pina T, Miranda-Filloy JA, Navas Parejo A, Argila D, Aragües M, Rubio-Romero E, Leon Luque M, Blanco Madrigal JM, Galindez-Agirregoikoa E, Jayne D, Blanco R, Martin J, González-Gay MA. A Genome-Wide Association Study Suggests the HLA Class II Region As the Major Susceptibility Locus for IgA Vasculitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-genome-wide-association-study-suggests-the-hla-class-ii-region-as-the-major-susceptibility-locus-for-iga-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-genome-wide-association-study-suggests-the-hla-class-ii-region-as-the-major-susceptibility-locus-for-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology